Navigation Links
6 percent of Spanish workers have high cardiovascular risk
Date:5/10/2011

The first study into the prevalence of overall cardiovascular risk in the Spanish working population (ICARIA) shows that 6% of workers have a high risk (8% on men and 2% in women). This prevalence increases with age in both sexes, and is highest in the farming sector, followed by construction, industry and services.

"In Spain, approximately one million workers have a high level of cardiovascular risk, but only a minority of these people classify themselves as at risk", Miguel ngel Snchez Chaparro, coordinator of the ICARIA study and a researcher at the University of Malaga (UMA), tells SINC. "These figures show that most of them are probably unaware of their risk level".

The study, published in the journal Nutrition, Metabolism & Cardiovascular Diseases, reveals that 6% of workers have high overall cardiovascular risk (8% of men and 2% of women), while for 1% the risk is moderate. In addition, the prevalence of high risk increases with age in both sexes, and is highest in the farming sector, followed by construction, industry and services.

The ICARIA study is the first piece of research to establish this risk in all of Spain's autonomous regions, industrial sectors and jobs. It was carried out between May 2004 and June 2005 among more than 300,000 apparently healthy workers, with an average age of 36.

Among other conclusions, the study indicates a higher prevalence of high cardiovascular risk among blue collar workers than in white collar workers, in both sexes.

"The differences we found are related to the greater prevalence of risk factors in these sectors of activity and could help to set priorities for prevention", says Snchez Chaparro.

The authors stress the importance of stratifying global cardiovascular risk, which could help contribute to more efficient prevention of cardiovascular disease, above given that these measures apply to people who are mostly young and healthy, and who do not usua
'/>"/>

Contact: SINC
info@plataformasinc.es
0034-914-251-820
FECYT - Spanish Foundation for Science and Technology
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. New study reveals autism prevalence in South Korea estimated to be 2.6 percent or 1 in 38 children
2. Deaths from drug overdose decline 35 percent after the opening of supervised injection site
3. Overdose deaths down 35 percent after opening of Vancouvers supervised injection site: UBC-BC-CfE study
4. New survey: 72 percent of Americans think health-care system needs major overhaul
5. Regional prevention project involving 10,000 adults cuts heart attacks by 25 percent
6. Quadruple therapy shows 100 percent SVR for HCV patients previously unresponsive to treatment
7. Around 25 percent of health messages in Spanish text books are not based on scientific evidence
8. Study finds reports of domestic violence rise 10 percent after NFL upsets
9. 70 percent of prostate cancer patients on ADT gain significant weight in first year
10. Experts call for greater pain assessment in hospitals as 65 percent of patients report problems
11. Hearing loss rate in older adults climbs to more than 60 percent in national survey
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
6 percent of Spanish workers have high cardiovascular risk
(Date:7/31/2015)... ... July 31, 2015 , ... Creating one of the most modern fertility ... a visionary image that goes beyond the boundaries of fertility medicine. , As ... extraordinary heights with dependable patient support, affordable treatments, unending hope, and high fertility success ...
(Date:7/31/2015)... ... , ... The Mount Sinai Health System will work with Columbia Care LLC, ... experimental treatments. The collaboration moves into the next phase with the recent decision by ... state licenses to produce and dispense medical marijuana. , Mount Sinai and Columbia ...
(Date:7/31/2015)... ... July 31, 2015 , ... Recently, ZKB filed ... Ohio, Western Division (Case No. 3:15-cv-00397) involving the Implanon® contraceptive implant . ... migration of their Implanon® implants, inability to locate the implants, unsuccessful and invasive ...
(Date:7/31/2015)... ... 31, 2015 , ... Florida Hospital Tampa has started treating ... for targeted delivery of fluids to selected sites in the peripheral vascular system. ... with the device that provides direct, local delivery of chemotherapy to the pancreas. ...
(Date:7/31/2015)... ... 31, 2015 , ... Awarded to only the Top 10 hair transplant practices ... are the latest recipients of the Center of Clinical Excellence for ARTAS Robotic ... leaders in the science of hair transplant. , Parsa Mohebi Hair Restoration is known ...
Breaking Medicine News(10 mins):Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 2Health News:New Hope IVF Now Offers Most Affordable Assisted Reproductive Treatment in the UAE 3Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 3Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 2Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 4Health News:Prestigious Medical Award Given To Parsa Mohebi Hair Restoration for Excellence in Hair Transplantation 2
... GENCO Supply Chain Solutions, company, to present, ... during U.S. Environmental Protection Agency,s (Region III) Pharmaceutical ... ... Capital Returns, Inc. (CRI), the,pharmaceutical industry,s leading processor of ...
... WALNUT CREEK, Calif., June 5 Longs Drug,Stores Corporation (NYSE: LDG ) today reported preliminary total retail drug,store sales for the four-week and seventeen-week periods ended ... Periods ended ... ... (4 weeks) (17 weeks), Total retail drug ...
... OSHA ,Star Site, PITTSBURGH, June 5 ... Cranberry, Pa. manufacturing plant has been designated a,national ... Occupational,Safety and Health Administration (OSHA). Fewer than 85 ... the U.S. have earned,this distinction since the VPP ...
... Closer Look at The Value of,MRIs is now ... website, http://www.msassociation.org . This three part video,features: ... first-hand,account on the experience of undergoing an MRI; ... the importance of MRIs to monitor disease,progression; and ...
... Awarded Top Juice Beverage by Health Magazine, SEATTLE, ... and,juice producers, and its Yellow Mango Orchard natural 100 ... Buys in 2008 by Health,Magazine., With the help ... products in beauty, food and fitness to the ultimate ...
... 5 Benchmarking is not a luxury;,it is an ... research,excerpt presents a survey analysis of 30 companies and ... are using benchmarking in a,difficult economy., The complete ... to benchmark, the goals of benchmarking studies, how companies ...
Cached Medicine News:Health News:Pioneering Safe Medication Return Initiative Reviewed During Pharmaceutical Disposal Summit 2Health News:Longs Reports Preliminary May Retail Drug Store Sales 2Health News:MSA Cranberry Plant Named One of Safest in Country 2Health News:MSA Cranberry Plant Named One of Safest in Country 3Health News:Photos: The Multiple Sclerosis Association of America Produces a Web Video on the Importance of MRIs 2Health News:Kagome's Yellow Mango Orchard Blended Juice Named One of America's Healthiest Buys 2Health News:Kagome's Yellow Mango Orchard Blended Juice Named One of America's Healthiest Buys 3Health News:Demonstrating the Value of Benchmarking in an Uncertain Economy 2
(Date:7/30/2015)... -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today ... the second quarter ending June 30, 2015. ... organization.  We are excited to be near the completion ... conducted with topline results expected in the fourth quarter," ... Therapeutics, Inc. "Translarna is now commercially available in 12 ...
(Date:7/30/2015)... CHENGDU, China , July 30, 2015 ... "Company"), a pharmaceutical company that specializes in the patented ... active pharmaceutical ingredients (API), provided updates regarding the notice ... MKT LLC (the "Exchange") indicating that the Company was ... set forth in Sections 134 and 1101 of the ...
(Date:7/30/2015)... 30, 2015 Eisai Inc. announced today that ... United States , European Union and ... respectively) for eribulin, for the treatment of patients with ... chemotherapy for advanced or metastatic disease. ... pivotal global Phase 3 clinical trial (Study 309), which ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5
... SUNNYVALE, Calif., Oct. 24, 2011 Accuray Incorporated (Nasdaq: ... that it will report results for its first quarter of ... 8, 2011 after the market closes. A conference ... fiscal year 2012 will begin at 2:00 p.m. PST/5:00 p.m. ...
... Awarepoint Corporation , the leading provider of ... the hiring of four senior management executives to support ... solutions in hospitals and clinics. Merrie Wallace, R.N., B.S.N., ... solutions, reporting to Awarepoint CEO Jay Deady. Chris Cosgrove ...
Cached Medicine Technology:Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2012 2Awarepoint Expands Senior Management Team 2Awarepoint Expands Senior Management Team 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: